Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Clinical trial NCT05533697 · RECRUITING
Trial details
- NCT number
- NCT05533697
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2032-02-18
- Enrollment
- 361
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.